CWRU, UH researchers test noninvasive esophageal cancer screening technology
A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...
Targeted Oncology4h
Kato Breaks Down FDA Approval of Tislelizumab in Esophageal Cancer
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Unveiling Pharma Market Potential: Delveinsight's Strategic Insights Into The Rapidly Expanding MASH Landscape In Asia
A case study on how DelveInsight helped a pharma client navigate the evolving metabolic dysfunction-associated steatohepatitis (MASH) landsca ...
North Carolina Health News9h
Unraveling an oral health mystery leads to rare autoimmune diagnosis
Autoimmune, pemphigus, dermatology, medical odyssey, oral health mystery, oral health, blisters, OASIS, Lupus, Sjogren's, ...